SCM

Stonepine Capital Management Portfolio holdings

AUM $114M
1-Year Est. Return 77.6%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+77.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$114M
AUM Growth
-$12.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
86
New
Increased
Reduced
Closed

Top Buys

1
+$13M
2
+$5.51M
3
+$3.52M
4
CRIS icon
Curis
CRIS
+$3.41M
5
SLGL icon
Sol-Gel Technologies
SLGL
+$2.01M

Top Sells

1
+$3.59M
2
+$2.47M
3
+$2.39M
4
ELDN icon
Eledon Pharmaceuticals
ELDN
+$2.02M
5
EDSA icon
Edesa Biotech
EDSA
+$1.97M

Sector Composition

1 Healthcare 100%
2 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTMX icon
26
CytomX Therapeutics
CTMX
$690M
$940K 0.83%
+200,000
PMVP icon
27
PMV Pharmaceuticals
PMVP
$67.2M
$878K 0.77%
708,102
-442,657
BIOA
28
BioAge Labs
BIOA
$721M
$875K 0.77%
50,000
+5,000
CNTB
29
Connect Biopharma Holdings
CNTB
$142M
$812K 0.71%
+310,000
RADX
30
Radiopharm Theranostics
RADX
$35.9M
$739K 0.65%
51,000,000
MXCT icon
31
MaxCyte
MXCT
$127M
$706K 0.62%
1,004,673
+535,655
CDXS icon
32
Codexis
CDXS
$246M
$681K 0.6%
417,994
+161,888
BOLD
33
Boundless Bio
BOLD
$32.1M
$657K 0.58%
597,682
-112,389
HELP
34
Cybin Inc
HELP
$227M
$643K 0.57%
134,060
-205,842
ZNTL icon
35
Zentalis Pharmaceuticals
ZNTL
$276M
$630K 0.55%
269,100
-194,600
KTTA icon
36
Pasithea Therapeutics
KTTA
$23.2M
$617K 0.54%
831,301
+556,239
MSLE
37
Satellos Bioscience
MSLE
$146M
$563K 0.5%
+100,000
PHAT icon
38
Phathom Pharmaceuticals
PHAT
$760M
$556K 0.49%
+50,010
OKUR
39
OnKure Therapeutics
OKUR
$175M
$549K 0.48%
+132,578
XLO icon
40
Xilio Therapeutics
XLO
$54.5M
$540K 0.47%
64,162
+55,143
VRCA icon
41
Verrica Pharmaceuticals
VRCA
$101M
$528K 0.46%
99,735
-253,934
CADL icon
42
Candel Therapeutics
CADL
$614M
$502K 0.44%
+102,500
POCI icon
43
Precision Optics
POCI
$61.6M
$439K 0.39%
+100,000
QNRX
44
Quoin Pharmaceuticals
QNRX
$9.64M
$353K 0.31%
53,460
-24,729
ESTA icon
45
Establishment Labs
ESTA
$2.1B
$341K 0.3%
+6,000
UPB
46
Upstream Bio Inc
UPB
$400M
$315K 0.28%
+35,000
IRD
47
Opus Genetics
IRD
$321M
$313K 0.27%
+68,688
ARVN icon
48
Arvinas
ARVN
$528M
$292K 0.26%
+27,500
PLRX icon
49
Pliant Therapeutics
PLRX
$73.7M
$283K 0.25%
224,650
-5,400
JANX icon
50
Janux Therapeutics
JANX
$854M
$278K 0.24%
20,000
1
2
3 4